title: Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
authors.affiliation: Allergy Unit, Hospital Universitario de Fuenlabrada, Madrid, Spain. Electronic address: dgolano@yahoo.es.
authors.forename: David
authors.initials: D
authors.lastname: González-de-Olano
authors.affiliation: Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain.
authors.forename: Jose M
authors.initials: JM
authors.lastname: Morgado
authors.affiliation: Allergy Unit, Hospital Universitario de Fuenlabrada, Madrid, Spain.
authors.forename: Raquel
authors.initials: R
authors.lastname: Juárez-Guerrero
authors.affiliation: Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Sánchez-Muñoz
authors.affiliation: Pharmacy Department, Hospital Universitario de Fuenlabrada, Madrid, Spain.
authors.forename: Javier
authors.initials: J
authors.lastname: Letellez-Fernández
authors.affiliation: Oncology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain.
authors.forename: Diego
authors.initials: D
authors.lastname: Malón-Giménez
authors.affiliation: Allergy and Immunology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
authors.forename: Mariana C
authors.initials: MC
authors.lastname: Castells
mesh_terms: D000328:Adult; D000707:Anaphylaxis / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D015549:Basophil Degranulation Test; D001491:Basophils / Q000276:immunology*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; C485206:pertuzumab